152 related articles for article (PubMed ID: 25065170)
1. [Chronic Lymphocytic Leukemia. New targeted therapy option Ibrutinib].
Bruhn C
Med Monatsschr Pharm; 2014 Jul; 37(7):268-9. PubMed ID: 25065170
[No Abstract] [Full Text] [Related]
2. Ibrutinib for Chronic Lymphocytic Leukemia.
Ruchlemer R; Ben Ami R; Lachish T
N Engl J Med; 2016 Apr; 374(16):1593-4. PubMed ID: 27096597
[No Abstract] [Full Text] [Related]
3. Ibrutinib for Chronic Lymphocytic Leukemia.
Rigolin GM; Cavazzini F; Cuneo A
N Engl J Med; 2016 Apr; 374(16):1593. PubMed ID: 27096596
[No Abstract] [Full Text] [Related]
4. Ibrutinib for Chronic Lymphocytic Leukemia.
Sharman JP; Mato AR; Keating MJ
N Engl J Med; 2016 Apr; 374(16):1592-3. PubMed ID: 27096595
[No Abstract] [Full Text] [Related]
5. Ibrutinib for Chronic Lymphocytic Leukemia.
Burger JA; Styles L; Kipps TJ
N Engl J Med; 2016 Apr; 374(16):1594-5. PubMed ID: 27096594
[No Abstract] [Full Text] [Related]
6. Ibrutinib and its use in the treatment of chronic lymphocytic leukemia.
Frustaci AM; Tedeschi A; Deodato M; Mazzucchelli M; Cairoli R; Montillo M
Future Oncol; 2018 Apr; 14(8):681-697. PubMed ID: 29243946
[TBL] [Abstract][Full Text] [Related]
7. Ibrutinib in relapsed chronic lymphocytic leukemia.
Neffendorf JE; Gout I; Hildebrand GD
N Engl J Med; 2013 Sep; 369(13):1277. PubMed ID: 24066759
[No Abstract] [Full Text] [Related]
8. Ibrutinib in relapsed chronic lymphocytic leukemia.
Byrd JC; O'Brien S; James DF
N Engl J Med; 2013 Sep; 369(13):1278-9. PubMed ID: 24066758
[No Abstract] [Full Text] [Related]
9. Spuriously low lymphocyte count associated with pseudoerythroblastemia in a patient with chronic lymphocytic leukemia treated with ibrutinib.
Robier C; Beham-Schmid C; Neubauer M
Clin Chem Lab Med; 2018 Apr; 56(5):e112-e114. PubMed ID: 29252190
[No Abstract] [Full Text] [Related]
10. Ibrutinib (Imbruvica) for chronic lymphocytic leukemia.
Med Lett Drugs Ther; 2014 Apr; 56(1440):29-30. PubMed ID: 24736247
[No Abstract] [Full Text] [Related]
11. Resolution of eosinophilia and elevated immunoglobulin E with ibrutinib for chronic lymphocytic leukemia.
Harada K; Brooks JP; Lobo FM
Ann Allergy Asthma Immunol; 2018 Nov; 121(5):629-630.e1. PubMed ID: 30009879
[No Abstract] [Full Text] [Related]
12. A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib.
Lee CS; Rattu MA; Kim SS
J Oncol Pharm Pract; 2016 Feb; 22(1):92-104. PubMed ID: 25425007
[TBL] [Abstract][Full Text] [Related]
13. Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia.
Tam CS; Kimber T; Seymour JF
Br J Haematol; 2017 Mar; 176(5):829-831. PubMed ID: 26915463
[No Abstract] [Full Text] [Related]
14. Ibrutinib increased survival more than chlorambucil in older patients with untreated chronic lymphocytic leukemia.
Aronson FR
Ann Intern Med; 2016 Apr; 164(8):JC44. PubMed ID: 27089094
[No Abstract] [Full Text] [Related]
15. The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands.
van der Straten L; Levin MD; Visser O; Blijlevens NMA; Cornelissen JJ; Doorduijn JK; Kater AP; Dinmohamed AG
Br J Haematol; 2020 Mar; 188(6):e109-e112. PubMed ID: 31991479
[No Abstract] [Full Text] [Related]
16. The use of ibrutinib in chronic lymphocytic leukemia.
Damon LE
Clin Adv Hematol Oncol; 2016 Mar; 14(3):154-6. PubMed ID: 27058026
[No Abstract] [Full Text] [Related]
17. Life after ibrutinib? A new unmet need in CLL.
Pinilla-Ibarz J; Chavez JC
Blood; 2015 Mar; 125(13):2013-4. PubMed ID: 25814485
[TBL] [Abstract][Full Text] [Related]
18. [Ibrutinib in the treatment of chronic lymphocytic leukemia and other B-cell malignancies].
Wang M; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):245-9. PubMed ID: 24598688
[TBL] [Abstract][Full Text] [Related]
19. Deciphering Ibrutinib Resistance in Chronic Lymphocytic Leukemia.
Lenz G
J Clin Oncol; 2017 May; 35(13):1451-1452. PubMed ID: 28291389
[No Abstract] [Full Text] [Related]
20. Ibrutinib and rituximab for chronic lymphocytic leukaemia.
Stirrups R
Lancet Oncol; 2019 Sep; 20(9):e471. PubMed ID: 31402323
[No Abstract] [Full Text] [Related]
[Next] [New Search]